LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Neratinib | 3.33 | uM | LJP5 | 1 | A14 | 72 | hr | 1389 | 3218 | 5772 | 0.5575 | 0.5050 |
| MCF7 | Neratinib | 3.33 | uM | LJP5 | 3 | A14 | 72 | hr | 1389 | 3215 | 6038 | 0.5324 | 0.4856 |
| MCF7 | Neratinib | 10 | uM | LJP5 | 1 | A13 | 72 | hr | 1389 | 2152 | 5772 | 0.3728 | 0.2374 |
| MCF7 | Neratinib | 10 | uM | LJP5 | 3 | A13 | 72 | hr | 1389 | 1930 | 6038 | 0.3196 | 0.1678 |
| MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 1 | B24 | 72 | hr | 1389 | 3358 | 5147 | 0.6524 | 0.5954 |
| MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 2 | B24 | 72 | hr | 1389 | 4202 | 5447 | 0.7713 | 0.7532 |
| MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 3 | B24 | 72 | hr | 1389 | 3798 | 5740 | 0.6616 | 0.6345 |
| MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 1 | B23 | 72 | hr | 1389 | 3011 | 5147 | 0.5850 | 0.5059 |
| MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 2 | B23 | 72 | hr | 1389 | 3894 | 5447 | 0.7148 | 0.6868 |
| MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 3 | B23 | 72 | hr | 1389 | 3882 | 5740 | 0.6763 | 0.6521 |
| MCF7 | JW-7-24-1 | 0.37 | uM | LJP6 | 1 | B22 | 72 | hr | 1389 | 2626 | 5147 | 0.5102 | 0.4008 |
| MCF7 | JW-7-24-1 | 0.37 | uM | LJP6 | 2 | B22 | 72 | hr | 1389 | 3638 | 5447 | 0.6678 | 0.6296 |
| MCF7 | JW-7-24-1 | 0.37 | uM | LJP6 | 3 | B22 | 72 | hr | 1389 | 2917 | 5740 | 0.5081 | 0.4368 |
| MCF7 | JW-7-24-1 | 1.11 | uM | LJP6 | 1 | B21 | 72 | hr | 1389 | 2183 | 5147 | 0.4241 | 0.2703 |
| MCF7 | JW-7-24-1 | 1.11 | uM | LJP6 | 2 | B21 | 72 | hr | 1389 | 2712 | 5447 | 0.4978 | 0.4040 |
| MCF7 | JW-7-24-1 | 1.11 | uM | LJP6 | 3 | B21 | 72 | hr | 1389 | 2423 | 5740 | 0.4221 | 0.3123 |
| MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 1389 | 1690 | 5147 | 0.3283 | 0.1094 |
| MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1389 | 2223 | 5447 | 0.4080 | 0.2694 |
| MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1389 | 2171 | 5740 | 0.3782 | 0.2438 |
| MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1389 | 908 | 5147 | 0.1764 | -0.2015 |
| MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1389 | 1133 | 5447 | 0.2080 | -0.0982 |
| MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1389 | 1138 | 5740 | 0.1982 | -0.0928 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1389 | 1370 | 5147 | 0.2662 | -0.0073 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1389 | 1476 | 5447 | 0.2709 | 0.0313 |
| MCF7 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1389 | 1694 | 5740 | 0.2951 | 0.1018 |